The Pharmacology and Toxicology of Atypical Antipsychotic Agents
- 1 January 2001
- journal article
- review article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 39 (1) , 1-14
- https://doi.org/10.1081/clt-100102873
Abstract
Recently, atypical antipsychotic agents have largely replaced traditional agents as first-line drugs for the treatment of schizophrenia. It is likely that atypical agents will soon account for the majority of poisonings from antipsychotic agents that present to health care facilities in the US. This article reviews the pharmacodynamics, pharmacokinetics, and toxicology of atypical antipsychotic drugs, chiefly clozapine, risperidone, olanzapine, and quetiapine. A descriptive summary of the human overdose experience with these agents is provided. Adverse effect and drug interaction data are reviewed. Based on the available pharmacodynamic, pharmacokinetic, and human overdose data, recommendations on management are provided.Keywords
This publication has 80 references indexed in Scilit:
- Olanzapine overdose in a 1-year-old malePediatric Emergency Care, 1999
- Olanzapine OverdoseAnnals of Emergency Medicine, 1998
- Safety in Overdose of QuetiapineThe Journal of Clinical Psychiatry, 1998
- Acute clozapine overdosageThe British Journal of Psychiatry, 1997
- Pharmacokinetics of Clozapine and RisperidoneJournal of Clinical Psychopharmacology, 1996
- Overdose of risperidoneAnnals of Emergency Medicine, 1993
- Clozapine cases with fatal, toxic or therapeutic concentrationsInternational journal of legal medicine, 1993
- Pharmacokinetics and Pharmacodynamics of ClozapineClinical Pharmacokinetics, 1993
- Antipsychotic Drugs: Prediction of Side-Effect Profiles Based on Neuroreceptor Data Derived From Human Brain TissueMayo Clinic Proceedings, 1987
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976